Home › NDC Lookup › Ingredients › Fexofenadine Hydrochloride › 73581-0025-01
Fexofenadine Hydrochloride 60 mg Tablet, 10-count — NDC 73581-0025-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Fexofenadine Hydrochloride 60 mg Tablet, 10-count — NDC 73581-025-01 (Billing 73581-0025-01)

by YYBA Corp · 10 TABLET in 1 BOTTLE

This is a package of 10 tablets of Fexofenadine Hydrochloride 60 mg Tablet from YYBA Corp, marketed since Dec 2025 and currently FDA-listed. It is the main listing for this product, which comes in 3 package sizes.

NDC 73581-0025-01
🏷️ FDA NDC (as labeled) 73581-025-01 billing pads the product segment with a zero
This package
Contains10-count Pack sizes3 compare ↓
Main listing for product 73581-025 · Also comes in: 60 tablets 73581-025-06 200 tablets 73581-025-20
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 73581-025-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
73581 labeler · 025 product · 01 package
Package marketed since
Dec 18, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 7358102501 5
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 73581-025-01
Product NDC 73581-025
11-digit billing NDC 73581002501
RxCUI 997420, 997501
UNII 2S068B75ZU
Application # ANDA211075
SPL Set ID 53e87aa4-9db3-9ded-e063-6294a90a319e
Established class (EPC) Histamine-1 Receptor Antagonist
Mechanism of action Histamine H1 Receptor Antagonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-12-18
Route ORAL
Dosage form TABLET
Substance FEXOFENADINE HYDROCHLORIDE
Quick answers
  • RxCUI (RxNorm): 997420
Why two NDCs? The FDA registers this code as 73581-025-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 73581-0025-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Histamine-1 Receptor Antagonist class.

Pharmacologic class Histamine-1 Receptor Antagonist
Drug family (ATC) Other antihistamines for systemic use
How it works Histamine H1 Receptor Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 What it is MedlinePlus · NLM

Fexofenadine is used to treat allergy symptoms: runny nose sneezing red, itchy, or watering eyes itching of the nose or throat It is also used to treat itching and redness caused by hives. Fexofenadine is in a class of medications called antihistamines. It works by blocking the effects of histamine, a substance in the body that causes allergy symptoms.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Fexofenadine is an antihistamine that relieves common allergy symptoms — things like a runny nose, sneezing, itchy or watery eyes, and an itchy nose or throat caused by hay fever o...
  • The FDA labels for fexofenadine do not list drowsiness as a side effect in the consumer sections provided. That said, everyone responds a little differently, so pay attention to ho...
  • You'll want to be careful here. The label says not to take fexofenadine at the same time as aluminum or magnesium antacids — the kind used for heartburn or upset stomach — and to a...
  • Can I take fexofenadine with my antacids or a glass of orange juice?
📖 Read our full Fexofenadine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 60 tablets 200 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
73581-0025-01 You're viewing this Main listing 10 TABLET in 1 BOTTLE 2025-12-18 — Active
73581-0025-06 73581-025-06 60 TABLET in 1 BOTTLE 2025-12-18 — Active
73581-0025-20 73581-025-20 200 TABLET in 1 BOTTLE 2025-12-18 — Active

You're viewing the smallest of 3 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 10-count package — 10 tablet in 1 bottle.
How does this package differ from NDC 73581-0025-06?
Both are Fexofenadine Hydrochloride 60 mg Tablet — the drug itself is identical. This page's package is the 10-count one, while NDC 73581-0025-06 is the 60 tablets package.
What NDC number is used to bill for this package of Fexofenadine Hydrochloride 60 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
fexofenadine hcl 60 mg 00904-7192-40 Major 500 tablets $0.153 — Availability likely —
Fexofenadine hydrochloride 60 mg 55111-0783-01 Dr. 100 tablets $0.153 — Availability likely —
Fexofenadine hydrochloride 60 mg 68001-0439-00 BluePoint 100 tablets $0.153 — Availability likely —
Fexofenadine HCl 60 mg 69230-0201-05 Camber 500 tablets $0.153 — Availability likely —
12HR Allergy Relief 60 mg 70000-0586-01 CARDINAL 12 tablets $0.153 — Availability likely —
Allergy Relief 60 mg 70677-1008-01 Strategic 24 tablets $0.153 — Discontinued —
Allergy Relief 60 mg 83324-0009-12 Chain 12 tablets $0.153 — Availability likely —
Fexofenadine hydrochloride 60 mg 00363-0783-24 Walgreens 24 tablets — — FDA listed —
Fexofenadine HCL 60 mg 00363-9765-24 Walgreens 24 tablets — — FDA listed —
Fexofenadine HCl 60 mg 11822-7652-04 Rite 24 tablets — — FDA listed —
Allergy Relief 60 mg 11822-9995-01 Rite 24 tablets — — Discontinued —
Fexofenadine Hydrochloride 60 mg 30142-0091-12 Kroger 12 tablets — — Discontinued —
Allergy Relief 60 mg 37808-0391-02 HEB 12 tablets — — FDA listed —
Allegra Allergy 60 mg 41167-4131-02 Chattem, 12 tablets — — FDA listed —
Fexofenadine Hydrochloride 60 mg 43598-0936-01 Dr. 100 tablets — — FDA listed —
fexofenadine hcl 60 mg 50228-0201-01 ScieGen 30 tablets — — FDA listed —
Crcle Fexofenadine Hydrochloride 60 mg 57483-0230-01 Innovus 100 tablets — — FDA listed —
Fexofenadine Hydrochloride 60 mg 62207-0765-49 Granules 1000 tablets — — FDA listed —
Fexofenadine Hydrochloride 60 mg 62207-0889-49 Granules 1000 tablets — — FDA listed —
Allergy Relief 60 mg 63548-0663-05 PLD 500 tablets — — FDA listed —
Allergy Relief 60 mg 63868-0819-12 Chain 12 tablets — — Discontinued —
Allergy Relief Non Drowsy 60 mg 69168-0437-06 Allegiant 120 tablets — — FDA listed —
Fexofenadine HCL 60 mg 69230-0301-01 Camber 100 tablets — — FDA listed —
Allergy Relief 60 mg 69842-0492-02 CVS 12 tablets — — FDA listed —
fexofenadine hcl 60 mg 71335-2165-01 Bryant 30 tablets — — FDA listed —
fexofenadine hcl 60 mg 71399-8659-01 AKRON 100 tablets — — FDA listed —
Allergy Relief 60 mg 72036-0191-03 HARRIS 288 tablets — — FDA listed —
Gencare-Allergy Relief 60 mg 72090-0068-01 Pioneer 100 tablets — — FDA listed —
Fexofenadine HCL 60 mg 73581-0010-01 YYBA 10 tablets — — FDA listed —
Fexofenadine Hydrochloride 60 mgthis 73581-0025-01 YYBA 10 tablets — — FDA listed —
Allergy Relief 60 mg 73581-0103-10 YYBA 100 tablets — — FDA listed —
fexofenadine hcl 60 mg 77771-0201-01 Radha 100 tablets — — FDA listed —
Fexofenadine Hydrochloride 60 mg 84324-0045-01 NUVICARE 60 tablets — — FDA listed —
Fexofenadine Hydrochloride 60 mg 58602-0877-09 Aurohealth 30 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Dec 2025
📍
2026
Currently FDA-listed
1 year listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color orange
ShapeOval
ImprintG6
Size17 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII 1K09F3G675
    Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
  • UNII EX438O2MRT
    Ferric oxide yellow is a naturally occurring iron compound used as a colorant in medications. It gives tablets, capsules, and other forms a yellow or golden hue for identification and appearance.
  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII 36SFW2JZ0W
    Hypromellose 2910 is a plant-based thickening agent derived from cellulose. In medicines, it forms a protective coating on tablets or capsules and controls how quickly the drug dissolves and releases into your body.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 30IQX730WE
    Polyethylene glycol 6000 is a synthetic polymer made from ethylene glycol units. It acts as a binder, filler, and solubilizer in medicines to help hold ingredients together, add bulk, and improve how well active drugs dissolve and absorb.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

12 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescolloidal silicon dioxide, croscarmellose sodium, hypromellose, iron oxide black, iron oxide red, iron oxide yellow, lactose monohydrate, macrogol, magnesium stearate, microcrystalline cellulose, pregelatinized starch, titanium dioxide.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerYYBA Corp
Application holderGRANULES INDIA LTD
FDA applicationANDA211075 (ANDA)
Labeler code73581
First marketedDec 2025
Product typeHuman Otc Drug
Portfolio78 products on file

More NDCs from YYBA Corp labeler code 73581

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 26 words ▾

USE(S) temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, water eyes sneezing itching of the nose or throat

⏱️ Dosage and Administration 82 words ▾

DIRECTIONS adults and children 12 years of age and over take one 60 mg tablet with water every 12 hours; do not take more than 2 tablets in 24 hours (for 60 mg) take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours (for 180 mg) children under 12 years of age do not use adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor

⚠️ Warnings 99 words ▾

WARNINGS Do not use if you have ever had an allergic reaction to this product or any of its ingredients. Ask a doctor before use if you have kidney disease. Your doctor should determine if you need a different dose.

When using this product do not take more than directed do not take at the same time as aluminum or magnesium antacids do not take with fruit juices (see Directions) Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. If pregnant or breast-feeding ask a health professional before use.

🧪 Active Ingredient 18 words ▾

ACTIVE INGREDIENT(S) Fexofenadine HCl USP 60 mg (for 60 mg) Fexofenadine HCl USP 180 mg (for 180 mg)

🧪 Inactive Ingredients 28 words ▾

INACTIVE INGREDIENTS colloidal silicon dioxide, croscarmellose sodium, hypromellose, iron oxide black, iron oxide red, iron oxide yellow, lactose monohydrate, macrogol, magnesium stearate, microcrystalline cellulose, pregelatinized starch, titanium dioxide.

🎯 Purpose 2 words ▾

PURPOSE Antihistamine

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 25 words ▾

QUESTIONS OR COMMENTS Contact 866-933-6337 Mon-Fri 9:00 AM EST to 5:00 PM PST MADE IN INDIA Distributed By: Wellspring Meds USA, Inc. Airmont, NY 10952

📄 Package Label / Principal Display Panel 5 words ▾

PRINCIPAL DISPLAY PANEL 200 100

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Fexofenadine hydrochloride — the ingredient across all brands.

Top reported reactions

Headache969
Fatigue954
Pruritus911
Nausea857
Diarrhoea766
Extra Dose Administered722
Dizziness720

Age at onset

Neonate6
Infant8
Child193
Adolescent247
Adult7,080
Elderly2,710

Reporter sex

21,660 reports
Male · 31%
Female · 69%
Unknown · 0%

Serious outcomes

Hospitalization2,929
Death693
Life-threatening353
Disabling346
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 2,118 1,274
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by YYBA Corp. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 60 tablets (73581-0025-06), 200 tablets (73581-0025-20). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
YYBA Corp is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 73581-0023-74 · YYBA 73581-0026-01 · YYBA →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.